SCOPUS 정보 검색 플랫폼

OncoImmunology

Volumn 2, Issue 4, 2013, Pages

The immunological identity of tumor: Self implications

(3) Miska, Jason a Devarajan, Priyadharshini a Chen, Zhibin a,b

a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE (United States)

b UNIVERSITY OF MIAMI (United States)

Author keywords

Altered self; Autoimmunity; Cancer; Immunoprivileged self; Regulatory T cell (Treg)

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; TRANSCRIPTION FACTOR FOXP3; TUMOR ANTIGEN;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CANCER CELL; CANCER CONTROL; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL ACTIVITY; CLINICAL FEATURE; EFFECTOR CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; INSULINOMA; LYMPHOMA CELL; MALIGNANT NEOPLASTIC DISEASE; REGULATORY T LYMPHOCYTE; RNA INTERFERENCE; SUPPRESSOR CELL; T CELL DEPLETION; TISSUE CHARACTERIZATION; TUMOR CELL DESTRUCTION; TUMOR ESCAPE; TUMOR IMMUNOLOGY;

EID: 84886945424 PISSN: 21624011 EISSN: 2162402X Source Type: Journal
DOI: 10.4161/onco.23794 Document Type: Article

Times cited : (5)

References (10)

1
- 77954801079
- Improved survival with ipilimumab in patients with metastatic melanoma
- PMID:20525992
- Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363:711-23; PMID:20525992; http://dx.doi.org/10.1056/NEJMoa1003466
- (2010) N Engl J Med , vol.363 , pp. 711-723
- Hodi, F.S.¹ O'Day, S.J.² McDermott, D.F.³ Weber, R.W.⁴ Sosman, J.A.⁵ Haanen, J.B.⁶

2
- 84862859820
- Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
- PMID:22658127
- Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012; 366:2443-54; PMID:22658127; http://dx.doi.org/10.1056/NEJMoa1200690
- (2012) N Engl J Med , vol.366 , pp. 2443-2454
- Topalian, S.L.¹ Hodi, F.S.² Brahmer, J.R.³ Gettinger, S.N.⁴ Smith, D.C.⁵ McDermott, D.F.⁶

3
- 84862903106
- Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
- PMID:22658128
- Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 2012; 366:2455-65; PMID:22658128; http:// dx.doi.org/10.1056/NEJMoa1200694
- (2012) N Engl J Med , vol.366 , pp. 2455-2465
- Brahmer, J.R.¹ Tykodi, S.S.² Chow, L.Q.³ Hwu, W.J.⁴ Topalian, S.L.⁵ Hwu, P.⁶

4
- 0015043748
- PMID:5279523
- Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971; 68:820-3; PMID:5279523; http://dx.doi.org/10.1073/ pnas.68.4.820
- (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A , vol.68 , pp. 820-823
- Knudson Jr., A.G.¹

5
- 0014887939
- The concept of immunological surveillance
- PMID:4921480
- Burnet FM. The concept of immunological surveillance. Prog Exp Tumor Res 1970; 13:1-27; PMID:4921480
- (1970) Prog Exp Tumor Res , vol.13 , pp. 1-27
- Burnet, F.M.¹

6
- 56749180605
- Immunotherapy of autoimmunity and cancer: the penalty for success
- PMID:19008897
- Caspi RR. Immunotherapy of autoimmunity and cancer: the penalty for success. Nat Rev Immunol 2008; 8:970-6; PMID:19008897; http://dx.doi.org/10.1038/ nri2438
- (2008) Nat Rev Immunol , vol.8 , pp. 970-976
- Caspi, R.R.¹

7
- 84867209754
- Autoimmunitymediated antitumor immunity: tumor as an immunoprivileged self
- PMID:22777737
- Miska J, Bas E, Devarajan P, Chen Z. Autoimmunitymediated antitumor immunity: tumor as an immunoprivileged self. Eur J Immunol 2012; 42:2584-96; PMID:22777737; http://dx.doi.org/10.1002/ eji.201242590
- (2012) Eur J Immunol , vol.42 , pp. 2584-2596
- Miska, J.¹ Bas, E.² Devarajan, P.³ Chen, Z.⁴

8
- 84874244373
- The privileged immunity of immune privileged organs: the case of the eye
- PMID:23049533
- Benhar I, London A, Schwartz M. The privileged immunity of immune privileged organs: the case of the eye. Front Immunol 2012; 3:296; PMID:23049533; http://dx.doi.org/10.3389/fimmu.2012.00296
- (2012) Front Immunol , vol.3 , pp. 296
- Benhar, I.¹ London, A.² Schwartz, M.³

9
- 0035554675
- The risk of autoimmunity associated with tumor immunotherapy
- PMID:11526387
- Gilboa E. The risk of autoimmunity associated with tumor immunotherapy. Nat Immunol 2001; 2:789-92; PMID:11526387; http://dx.doi.org/10.1038/ni0901-789
- (2001) Nat Immunol , vol.2 , pp. 789-792
- Gilboa, E.¹

10
- 84886943880
- OncoImmunology: a new journal at the frontier between oncology and immunology
- PMID:22720206
- Zitvogel L, Kroemer G. OncoImmunology: a new journal at the frontier between oncology and immunology. Oncoimmunology 2012; 1:1-2; PMID:22720206; http://dx.doi.org/10.4161/onci.1.1.17645
- (2012) Oncoimmunology , vol.1 , pp. 1-2
- Zitvogel, L.¹ Kroemer, G.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.